A Cleveland Clinic lab has found evidence to support the theory that age-related macular degeneration (AMD) is an inflammatory disease with varying ways to progress to advanced dry and wet AMD. Focusing on proteomic studies to discover biomarkers and molecular mechanisms of AMD and glaucoma, John W. Crabb, PhD, and his colleagues found many proteins associated with the immune response and cellular defense. The research goals are to develop methods that help clinicians identify who is susceptible to progression in age-related ocular disease, and that helps them assess the effectiveness of therapeutics.
Read the entire article here.